Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,686,772
+$3,508,820 QoQ
Shares Held
202,767
-26.3% QoQ
Ownership
0.697%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. ANAB ranks #98 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,686,772 | 202,767 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $10,177,952 | 183,519 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,817,734 | 181,884 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,988,127 | 195,563 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,357,036 | 196,263 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $3,957,537 | 212,886 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,912,623 | 219,986 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $6,697,074 | 199,913 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,864,781 | 194,125 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,529,864 | 201,149 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,437,109 | 207,148 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,595,168 | 200,177 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,120,211 | 202,567 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,236,521 | 332,560 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,526,217 | 339,665 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,573,850 | 336,097 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,863,106 | 338,085 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,687,925 | 270,329 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,798,470 | 281,970 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $7,806,572 | 287,853 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,754,820 | 299,067 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,056,566 | 234,643 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,586,588 | 259,842 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $4,017,087 | 272,346 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,472,954 | 289,748 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $4,364,854 | 308,907 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||